QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
15 hedge funds and large institutions have $527K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
15
Holding in Top 10
–
Calls
$32K
Puts
$3K
Top Buyers
| 1 | +$122K | |
| 2 | +$14K | |
| 3 | +$12K | |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$10K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.02K |
Top Sellers
| 1 | -$15.3K | |
| 2 | -$12K | |
| 3 | -$12K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.23K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$789 |